Close Menu

The Wall Street Journal runs an article profiling multimillionaire and melanoma patient Jay Tenenbaum and the company he founded, CollabRx, to get patients involved in helping develop therapeutics faster and for less money than the process currently takes. The projects that CollabRx takes on are called "virtual biotechs," according to the story, "because they aim to replicate many of the steps typically taken as part of a pharmaceutical or biotech company's search for a new drug."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.